Beck Bode’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
Beck Bode's CLB Position: Q2 2023 in Review
Beck Bode sold out of Core Laboratories (CLB) in Q2 2023, closing a stake of 219,503 shares — an estimated $4.84M sold.
Beck Bode first reported a position in CLB in Q3 2020 and held it in 2 quarters. The position peaked at $4.84M in Q1 2023. 164 funds tracked by Wall St. Rank hold CLB as of Q2 2023.
- Beck Bode reported no remaining Core Laboratories position as of Q2 2023 after selling out during the quarter.
- Beck Bode sold 219,503 Core Laboratories shares in Q2 2023, an estimated $4.84M.
- Beck Bode first reported a position in Core Laboratories in Q3 2020 and held it in 2 quarters.
- Beck Bode's Core Laboratories position peaked at $4.84M in Q1 2023.
- 164 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2023.
Based on Beck Bode's 13F filing for Q2 2023, filed 10 Aug 2023.